C

Catalyst Alpha

$VPCATALYSTVVince

About Catalyst Alpha

High-probability binary event investing focused on FDA approvals and other major corporate catalysts. High-risk, concentrated biotech portfolio.

About the Creator

Engineer and trader leveraging AI models to research catalyst events and build intelligent portfolios. Focused on systematic, data-driven approaches to identifying and capitalizing on market opportunities.

Activity

Total Rebalances79
Last RebalanceMar 2, 2026

Posts by Creator

See all
Changes:NVDA +13.0%DNLI +10.0%LNTH +5.4%RYTM +4.0%RCKT +3.0%

$VPCATALYST Selling ASND and BMRN after FDA approval. Adding NVDA for GTC cinference on March 16 and DNLI for FDA on April 5.

Changes:RYTM +2.1%ALDX +2.0%TVTX +1.0%LNTH +0.6%RCKT -4.7%

Locking in some of the RCKT >15% winnings and distributing to other positions.

Changes:ALDX +14.0%RYTM +12.0%TVTX +10.0%LNTH +8.0%RCKT +1.7%

Selling ETON after FDA news and adding ALDX, RYTM, TVTX, and LNTH; all with catalysts in next weeks.